Pfizer announced Friday that it would submit a request to the FDA Friday for its COVID-19 vaccine to be granted Emergency Use Authorization.
Pfizer announced Friday that it would submit a request to the FDA Friday for its COVID-19 vaccine to be granted Emergency Use Authorization.
Moderna is the second company in the U.S. to release its full trial results and apply for emergency use authorization.
WBZ TV's Nick Giovanni reports.